Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle‐invasive bladder cancer in a multisite, community‐based cohort

Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle‐invasive bladder cancer in a multisite, community‐based cohort

Background Nonmuscle‐invasive bladder cancer (NMIBC) has heterogeneous recurrence and progression outcomes. Available risk calculators estimate recurrence and progression but do not predict the recurrence stage or grade, which may influence downstream treatment. The objective of this study was to pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2021-02, Vol.127 (4), p.520-527
Hauptverfasser: Garg, Tullika, McMullen, Carmit K., Leo, Michael C., O’Keeffe‐Rosetti, Maureen C., Weinmann, Sheila, Nielsen, Matthew E.
Format: Artikel
Sprache:eng
Schlagworte:
Bladder
Bladder cancer
Calculators
Cancer
cancer progression
caner surveillance
Classification
clinical prediction rule
Diagnosis
Health hazards
Invasiveness
Medical diagnosis
Oncology
outcomes research
Patients
Progressions
Quality
Risk
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Nonmuscle‐invasive bladder cancer (NMIBC) has heterogeneous recurrence and progression outcomes. Available risk calculators estimate recurrence and progression but do not predict the recurrence stage or grade, which may influence downstream treatment. The objective of this study was to predict risk‐stratified NMIBC recurrence and progression based on recurrence tumor classification and grade. Methods In total, 2956 patients with NMIBC (
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.33300